Harris Todd's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Oct 22, 2024
- Accession no.
- 0000950170-24-116345
- Filed
- Oct 22, 2024
- Trade date
- Oct 18-21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.71M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harris ToddCIK 0001711463 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | Common Stock | SSaleDisposed | −43,636 | $27.01F2 | −$1,178,608.36 | 1,375,011 | Direct | |
| Oct 21, 2024 | Common Stock | SSaleDisposed | −5,896 | $27.32F3 | −$161,078.72 | 1,369,115 | Direct | |
| Oct 21, 2024 | Common Stock | SSaleDisposed | −13,188 | $28.16F4 | −$371,374.08 | 1,355,927 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.60 to $27.51. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.89 to $27.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.8957 to $28.5951. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.